Τόμος 19 (2005) – Τεύχος 2 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 19 (2005) – Issue 2 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

 

Title Risk in public health
Authors Kleanthi Gourounti and Katerina Lykeridou

Department of Midwifery, Technological Educational Institution of Athens, Ag. Spyridonos, Egaleo, Athens, Greece

Citation Gourounti, Κ., Lykeridou, Κ.: Risk In public health, Epitheorese Klin. Farmakol. Farmakokinet. 19(2): 93-97 (2005)
Publication Date Received for publication: : 23 March 2005

 Accepted for publication: 12 May 2005

Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Risk, risk assessment, risk perception, risk communication, risk management, prevention, public health.
Other Terms review article
Summary Risk is a probability of an adverse outcome or a factor that raises this probability. Over the past 20 years a number of definitions of risk have been proposed and it is noticed that all the definitions are referred to a probabilistic and a haz­ardous aspect. Most of the scientific effort and the financial resources are dedicated to treatment than prevention. Focusing on risk management is the key element to preventing disease and injury. Risk management usually applied to the whole process of risk identification, estimation, evaluation, reduc­tion and control and has the aim to control and re­duce the hazards to an acceptable level, to reduce the level of uncertainty in decision making about risks and to increase public trust in risk matters. Risk assessment is called a set of activities that include the focusing on the identification, quantifi­cation and characterization of the risk and usually is influenced by individuals’ perceptions concerning risks. The perception of risk is influenced from peo­ples’ beliefs, attitudes, judgments and feelings and also from biological characteristics of people like gender and age. Thus, the experts who will try to communicate the risk to the lay people must con­sider that the perception of risk among people var­ies and must adjust accordingly the way of risk communication. Control and minimization of risk demand not only the assessment of risk but also the successful cooperation and communication between experts and lay people. The effective risk communication will not succeed only the decrease of risk but also it will achieve the empowerment of the patients and the promotion of their autonomy in order for them to make an informed-sharing decision.
References 1.  Moore P.G. (ed.): The Business of Risk. Cambridge University Press, Cambridge, 1983

2.    World Health Organization: World Health Report, Defining and Assessing Risks to Health. WHO, 2002

3.    British Medical Association: The BMA Guide to Living with Risk. Penguin, London, 1990

4.    Backett E.M., Davies A.M., Petros-Barvazian A. (eds): The Risk Approach in Health Care. England: WHO, 1984

5.    Skolbekken J.A.: The risk epidemic in medical journals. Soc. Sci. Med. 40: 291-305 (1995)

6.    Hope T.: Rationing and life-saving treatments: should identifiable patients have higher priority? J. Med. Ethics 3: 179-185 (2001)

7.    Berry D.C. (ed.): Risk, Communication and Health Psychology. England Open University Press, 2004

8.    Cordis L. (ed.): Epidemiology and Health Risk Assessment. Oxford University Press, 1988

9.    Murray C.J.L., Lopez A.D. (eds). The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard University Press, Cambridge (MA), 1996

10.  Calman K.C. (ed.). The potential for health: how to improve the Nation’s health. Oxford University Press, Oxford, 1998

11.  Thornton H.: Patients’ understanding of risk, enabling understanding must not lead to manipulation. BMJ 327: 693-694 (2003)

12.  Mohanna K. (ed.): Risk Matters in Health Care: Communicating, Explaining and Managing Risk. Radcliffe Medical Press, U.K., 2001

13.  Flynn J., Slovic P., Mertz C.K.: Gender, age and perception of environmental risk. Risk Analysis 14: 1101-1108 (1994)

14.  Bennett P., Caiman K. (1999). Risk communication and public health. Oxford: Oxford University Press.

15.  Slovic P.: Perception of risk. Science 236: 280-285 (1987)

16.  Bennett P. (ed.): Communicating about Risks to Public Health: Pointers to Good Practice. Department of health, London, 1998

17.  Edwards A., Elwyn G., Mufley A.: Explaining risks: turning numerical data into meaningful pictures. BMJ 324: 827-830 (2002)

18.  Coveilo V.T. (ed.): Risk comparisons and risk communication: issues and problems in comparing health and environmental risks in R.E. 1991

19.  Kreps G.L.: The impact of communication on cancer risk incidence, morbidity, mortality, and quality of life, Health Communication 15: 161-169 (2003)

20.  Godolphin W.: The role of risk communication in shared decision making. BMJ 327: 692-693 (2003)

21.  Ong L.M. de Haes J.C., Hoos A.M., and Lammes F.B.: Doctor-patient communication: a review of the literature. Soc. Sci. Med. 40: 903-918 (1995)

22.  Flynn J., Slovic P., Mertz C.K.: Decidedly different: expert and public views of risks from a radioactive waste repository. Risk Analysis 13: 643-648 (1993)

23.  Slovic P.: Perceived risk, trust and democracy. Risk Analysis 13: 675-82 (1993)

24.  Gigirenzer G. and Edwards A. (2003). Simple tools for understanding risks: from innumeracy to insight. BMJ 327: 741-744 (2003)

25.  Paling J.: Strategies to help patients understand risk. BMJ 327: 745-748 (2003)

26.  Simpson M., Buckman R., Stewart M., Maquire P., Lipkin M.: Doctor-patient communication: the Toronto Consensus Statement, BMJ 303: 1385-1387 (1991)

27.  Phillips L., Bridgeman J„ Fergusan-Smith M. (eds): The Bovine Spongiform Encephalopathy (BSE) Inquiry (The Phillips Inquiry). Findings and Conclusions, Volume 1. The Stationery Office, London,2001

28.  Kasperson and P.J. Stallen (eds) Communicating risks to the public: International perspectives. Kluwer Academic Publishers.

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2005– ANNUAL SUBSCRIPTION 2005
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

 

Bookmark the permalink.

Comments are closed.